Marco Schmeer

1.2k total citations
34 papers, 908 citations indexed

About

Marco Schmeer is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Marco Schmeer has authored 34 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Genetics and 7 papers in Biotechnology. Recurrent topics in Marco Schmeer's work include RNA Interference and Gene Delivery (16 papers), Virus-based gene therapy research (13 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Marco Schmeer is often cited by papers focused on RNA Interference and Gene Delivery (16 papers), Virus-based gene therapy research (13 papers) and Viral Infectious Diseases and Gene Expression in Insects (7 papers). Marco Schmeer collaborates with scholars based in Germany, United States and Spain. Marco Schmeer's co-authors include Martin Schleef, Zoltán Ivics, Csaba Miskey, Razieh Monjezi, Michael Hudecek, Tea Gogishvili, Hermann Einsele, Lydia Alvarez‐Erviti, Wolfgang Walther and María Izco and has published in prestigious journals such as Science, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Marco Schmeer

32 papers receiving 875 citations

Peers

Countries citing papers authored by Marco Schmeer

Since Specialization

Citations

This map shows the geographic impact of Marco Schmeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Schmeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Schmeer more than expected).

Fields of papers citing papers by Marco Schmeer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Schmeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Schmeer. The network helps show where Marco Schmeer may publish in the future.

Co-authorship network of co-authors of Marco Schmeer

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Schmeer. A scholar is included among the top collaborators of Marco Schmeer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Schmeer. Marco Schmeer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of human targeted extracellular vesicles loaded with shRNA minicircles to prevent parkinsonian pathology 2025 ·Translational Neurodegeneration ·María Izco, Carme Solà, Martin Schleef, Marco Schmeer, María de Toro, Guglielmo Verona, (unknown), (unknown), (unknown), María Eugenia Marzo-Sola, Josune Garcı́a-Sanmartı́n, Joaquín Fernández‐Irigoyen, Enrique Santamaría, (unknown), Javier Blesa, Lydia Alvarez‐Erviti	0
2	Producing Plasmid DNA Template for Clinical Grade RNA Vaccine Manufacture 2024 ·Methods in molecular biology ·(unknown), Marco Schmeer, Martin Schleef	0
3	Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord 2023 ·Pharmaceutics ·María Izco, Martin Schleef, Marco Schmeer, (unknown), Guglielmo Verona, Lydia Alvarez‐Erviti	9
4	Capillary Gel Electrophoresis (CGE) for Quality Control of Plasmid DNA in Gene Therapy: Quality Control of 20 Years Stored GMP-Grade Plasmid DNA 2022 ·Methods in molecular biology ·Marco Schmeer, Martin Schleef, (unknown), Dennis Kobelt, Wolfgang Walther	3
5	Recombinant expression of Barnase in Escherichia coli and its application in plasmid purification 2021 ·Microbial Cell Factories ·(unknown), (unknown), Marco Schmeer, Joe Max Risse, Karl Friehs, Martin Schleef	5
6	Systemic Exosomal Delivery of shRNA Minicircles Prevents Parkinsonian Pathology 2019 ·Molecular Therapy ·María Izco, Javier Blesa, Martin Schleef, Marco Schmeer, Riccardo Porcari, Raya Al‐Shawi, Stéphan Ellmerich, María de Toro, Chris Gardiner, Yiqi Seow, (unknown), Raquel Forcén, J. Paul Simons, Vittorio Bellotti, Jonathan M. Cooper, Lydia Alvarez‐Erviti	173
7	Plasmid DNA Manufacturing for Indirect and Direct Clinical Applications 2017 ·Human Gene Therapy ·Marco Schmeer, (unknown), Martin Schleef	40
8	Low-Dose Gene Therapy for Murine PKU Using Episomal Naked DNA Vectors Expressing PAH from Its Endogenous Liver Promoter 2017 ·Molecular Therapy — Nucleic Acids ·Hiu Man Grisch‐Chan, (unknown), Tanja Scherer, Gabriella Allegri, (unknown), (unknown), Marco Schmeer, Martin Schleef, Cary O. Harding, Johannes Häberle, Beat Thöny	19
9	Self-Complementary Adeno-Associated Virus Vectors Improve Transduction Efficiency of Corneal Endothelial Cells 2016 ·PLoS ONE ·(unknown), (unknown), (unknown), Marco Schmeer, Martin Schleef, Friedrich E. Kruse, Thomas A. Fuchsluger	13
10	DNA Minicircle Technology Improves Purity of Adeno-associated Viral Vector Preparations 2016 ·Molecular Therapy — Nucleic Acids ·(unknown), Marco Schmeer, Barbara Kracher, (unknown), (unknown), (unknown), Thomas A. Fuchsluger, (unknown), Martin Schleef, Hildegard Büning	30
11	Enhanced CAR T-cell engineering using non-viral Sleeping Beauty transposition from minicircle vectors 2016 ·Leukemia ·Razieh Monjezi, Csaba Miskey, Tea Gogishvili, Martin Schleef, Marco Schmeer, Hermann Einsele, Zoltán Ivics, Michael Hudecek	194
12	Minicircle: Next Generation DNA Vectors for Vaccination 2015 ·Methods in molecular biology ·Martin Schleef, Reinhold Schirmbeck, Michael Reiser, Marie‐Louise Michel, Marco Schmeer	17
13	Production of Plasmid DNA as Pharmaceutical 2015 ·Methods in molecular biology ·Marco Schmeer, Martin Schleef	2
14	Pharmaceutical Grade Large-Scale Plasmid DNA Manufacturing Process 2014 ·Methods in molecular biology ·Marco Schmeer, Martin Schleef	14
15	A Seven-Year Storage Report of Good Manufacturing Practice–Grade Naked Plasmid DNA: Stability, Topology, and In Vitro/In Vivo Functional Analysis 2013 ·PubMed ·Wolfgang Walther, Marco Schmeer, Dennis Kobelt, (unknown), A. Harder, Volker Walhorn, Dario Anselmetti, Jutta Aumann, Iduna Fichtner, Martin Schleef	15
16	Minicircle DNA electrotransfer for efficient tissue-targeted gene delivery 2012 ·Gene Therapy ·Sophie Chabot, (unknown), Marco Schmeer, Martin Schleef, Muriel Golzio, Justin Teissié	58
17	Performance of High Quality Minicircle DNA for In Vitro and In Vivo Gene Transfer 2012 ·Molecular Biotechnology ·Dennis Kobelt, Martin Schleef, Marco Schmeer, Jutta Aumann, Peter M. Schlag, Wolfgang Walther	46
18	Minicircle – Die nächste Generation nicht‐viraler Gentherapie‐Vektoren. Zirkuläre, superspiralisierte Expressionskassetten ersetzen Plasmid‐DNA 2011 ·Pharmazie in unserer Zeit ·Martin Schleef, Marco Schmeer	2
19	Production of Non Viral DNA Vectors 2010 ·Current Gene Therapy ·Martin Schleef, (unknown), Marco Schmeer, (unknown), Corinne Marie, George Dickson, Daniel Scherman	22
20	Electroporative Gene Transfer 2009 ·Methods in molecular biology ·Marco Schmeer	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact